SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,462 Cr | ₹1,484 Cr | ₹1,487 Cr | ₹1,443 Cr | ₹1,463 Cr |
What is the latest Total Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹1,462 Cr |
Mar2023 | ₹1,484 Cr |
Mar2022 | ₹1,487 Cr |
Mar2021 | ₹1,443 Cr |
Mar2020 | ₹1,463 Cr |
How is Total Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,462 Cr | -1.46 | |
Mar2023 | ₹1,484 Cr | -0.19 | |
Mar2022 | ₹1,487 Cr | 3.02 | |
Mar2021 | ₹1,443 Cr | -1.38 | |
Mar2020 | ₹1,463 Cr | - |
Compare Total Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹3,397.8 Cr | -0.8% | -10.1% | 9.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,155.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,295.0 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
CIPLA | ₹116,664.0 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,678.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,162.6 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | -0.8% |
-10.1% |
9.2% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses